PASITHEA THERAPEUTICS CORP. (KTTA) Return on equity 2021–2022
PASITHEA THERAPEUTICS CORP. (KTTA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-32.8%FY2022 · since FY2021: -4.2% → -32.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -32.8% | -28.6 pp |
| FY2021 | -4.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More KTTA financial trends
KTTA RevenueKTTA Net incomeKTTA Net marginKTTA Gross profitKTTA Gross marginKTTA Operating incomeKTTA Operating marginKTTA Operating cash flowKTTA Free cash flowKTTA Capital expendituresKTTA Stock buybacksKTTA Dividends paidKTTA Total assetsKTTA Total liabilitiesKTTA Shareholders’ equityKTTA overview →